Category
Basic
Description
Gut-derived hormones such as glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) play essential roles in maintaining glucose homeostasis and appetite regulation. These hormones are primarily secreted by enteroendocrine L cells in response to nutrient signaling in the gut. Emerging evidence suggests that polyphenolic compounds and their metabolites may influence gut hormone secretion. Enterolactone (ENL), a microbial metabolite of the dietary lignan, matairesinol, is of particular interest due to its reported anti-diabetic properties. In this study, we propose to test whether ENL can modulate the secretion of GLP-1 and PYY in L cells in vitro, thereby identifying a potential mechanism by which ENL improves metabolic health.
Investigating Nutritionally Derived Treatments for Metabolic Disease: Enterolactone and Its Effect on GLP-1 and PYY Secretion
Basic
Gut-derived hormones such as glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) play essential roles in maintaining glucose homeostasis and appetite regulation. These hormones are primarily secreted by enteroendocrine L cells in response to nutrient signaling in the gut. Emerging evidence suggests that polyphenolic compounds and their metabolites may influence gut hormone secretion. Enterolactone (ENL), a microbial metabolite of the dietary lignan, matairesinol, is of particular interest due to its reported anti-diabetic properties. In this study, we propose to test whether ENL can modulate the secretion of GLP-1 and PYY in L cells in vitro, thereby identifying a potential mechanism by which ENL improves metabolic health.
